Novo Nordisk A/S

OTC: NONOF · Real-Time Price · USD
75.61
2.50 (3.43%)
At close: Jun 06, 2025, 3:43 PM

Novo Nordisk A/S Revenue

Novo Nordisk A/S reported an annual revenue of $290.4B, reflecting a 25.03% growth. For the quarter ending March 31, 2025, Novo Nordisk A/S generated $78.09B in revenue.
Revenue (ttm)
$290.4B
Revenue Growth
25.03%
Price / Sales Ratio
9.49
Revenue / Employee
$3.75M
Employees
77,406
Market Cap
335.65B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.